CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells

Experimental Hematology

Volumn 31, Issue 12, 2003, Pages 1275-1283

  Boiret, Nathalie ^a   Rapatel, Chantal ^a   Boisgard, Stéphane ^b   Charrier, Sabine ^a   Tchirkov, Andréi ^a   Bresson, Caroline ^a   Camilleri, Lionel ^a   Berger, Juliette ^a   Guillouard, Laurent ^a   Guérin, Jean Jacques ^a   Pigeon, Pascale ^a   Chassagne, Jacques ^a   Berger, Marc Gabriel ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; THY 1 ANTIGEN;

ADHERENT CELL; ANTIGEN EXPRESSION; ARTICLE; ASSAY; BONE MARROW; CELL COUNT; CELL MATURATION; CELL POPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROBLAST; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEGAKARYOCYTE; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING;

EID: 10744224947     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2003.08.010     Document Type: Article

References (53)

1. Verfaillie C.M., Almeida-Porada G., Wissink S., Zanjani E.D. Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow. Exp Hematol. 28:2000;1071-1079.
2. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 86:1995;2842-2848.
3. Cutler C., Giri S., Jeyapalan S., Paniagua D., Viswanathan A., Antin J.H. Acute and chronic graft-versus-host disease after allogenic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol. 19:2001;3685-3691.
4. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogenic barriers. Immunity. 11:1999;579-590.
5. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 285:1999;412-415.
6. Petersdorf E.W., Hansen J.A., Martin P.J., et al. Major- histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 345:2001;1794-1800.
7. Teshima T., Ferrara J.L. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol. 39:2002;15-22.
8. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276:1997;71-74.
9. Pittenger M.F., Maclay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
10. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 98:2001;2615-2625.
11. Lazarus H.M., Haynesworth S.E., Gerson S.L., Caplan A.I. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother. 6:1997;447-455.
12. Mareschi K., Biasin E., Piacibello W., Aglietta M., Madou E., Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 86:2001;1099-1100.
13. Blazsek I., Misset J.L., Benavides M., Cossimo M. Hematon, a multicellular functional unit in normal human bone marrow: structural organization, hematopoietic activity, and its relationship to myelodysplasia and myeloid leukemias. Exp Hematol. 18:1990;259-265.
14. Blazsek I., Liu X.H., Anjo A., Quittet P., Cossimo M. The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones. Exp Hematol. 23:1995;309-319.
15. Baum C.M., Weissman I.L., Tsukamoto A.S., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA. 89:1992;2804-2808.
16. + cells. Blood. 87:1996;949-955.
17. + hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol. 28:2000;858-870.
18. + hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant. 6:2000;262-271.
19. + hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 7:2001;680-687.
20. Makino S., Harada M., Akashi K., et al. A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing. Bone Marrow Transplant. 8:1991;239-244.
21. + peripheral blood progenitor cells (PBSCs), evaluated with an adapted serum-free methylcellulose assay, is predictive of platelet lineage reconstitution in children with solid tumors. J Hematother Stem Cell Res. 9:2000;525-534.
22. + cells from children contain the same levels of LTC-ICs producing the same numbers of CFCs as from adults, but display greater in vitro monocyte/macrophage potential. Br J Haematol. 112:2001;806-813.
23. Sutherland H.J., Lansdorp P.M., Henkelman D.H., Eaves A.C., Eaves C.J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA. 87:1990;3584-3588.
24. Friedenstein A.-J., Deriglasova U.-F., Kulagina N.-N., et al. Precursors for fibroblasts in different population of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 2:1974;83-92.
25. low/- precursors. Br J Haematol. 108:2000;610-620.
26. Rosu-Myles M., Gallacher L., Murdoch B., et al. The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc Natl Acad Sci USA. 97:2000;14626-14631.
27. Peled A., Kollet O., Ponomaryov T., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood. 95:2000;3289-3296.
28. Funk P.E., Kincade P.W., Witte P.L. Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates. Blood. 83:1994;361-369.
29. Blazsek I., Misset L.L., Comisso M., Mathé G. Hematon: a multicellular functional unit in primary hematopoiesis. Biomed Pharmacother. 42:1998;661-668.
30. Blazsek I., Marsalet B.D., Legras S., Machover D., Misset J.-L. Large scale recovery and characterization of stromal cell-associated primitive haemopoietic progenitor cell from filter-retained human bone marrow. Bone Marrow Transplant. 23:1999;647-657.
31. Dorshkind K. Regulation of hematopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol. 8:1990;111.
32. Bruno E., Luikart S.D., Long M.W., Hoffman R. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol. 23:1995;1212.
33. high stem cells to bone marrow stroma. J Clin Invest. 90:1992;358-367.
34. Morrison S.J., Shah N.M., Anderson D.J. Regulatory mechanisms in stem cell biology. Cell. 88:1997;287-298.
35. + cells contain primitive cells able to produce the different categories of CFU-Mk in vitro. Exp Hematol. 30:2002;1051-1060.
36. Zweegman S., Veenhof M.A., Huijgens P.C., Schuurhuis G.J., Drager A.M. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation. Exp Hematol. 28:2000;401-410.
37. Nagata Y., Nagahisa H., Nagasawa T., Todokoro K. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells. Leukemia. 11:(suppl 3):1997;435-438.
38. Barbara N.P., Wrana J.L., Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem. 274:1999;584-594.
39. Fortunel N.O., Hatzfeld A., Hatzfeld J.A. Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis. Blood. 96:2000;2022-2036.
40. + precursors. Blood. 98:2001;3635-3642.
41. Cashman J.D., Eaves A.C., Raines E.W., Ross R., Eaves C.J. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures I: stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta . Blood. 75:1990;96-101.
42. Sitnika E., Ruscetti W.F., Priestley G.V., Wolf N.S., Bartelmez S.H. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 88:1996;82-88.
43. + human hematopoietic progenitor. Exp Hematol. 24:1996;1509-1515.
44. Batard P., Monier M.N., Fortunel N., et al. TGF-(beta) 1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci. 113:2000;383-390.
45. Sakamaki S., Hirayama Y., Matsunaga T., et al. Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity. Blood. 94:1999;1961-1970.
46. Bianco P., Riminucci M., Gronthos S., Gehron Robey P. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 19:2001;180-192.
47. Galmiche M.C., Koteliansky V.E., Herve P., Charbord P. Stromal cells from human long term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood. 82:1993;66-76.
48. Majumdar M.-K., Thiede M.-A., Mosca J.-D., Moorman M., Gerson S.-L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 176:1998;57-66.
49. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 228:2000;875-884.
50. Lodie T.A., Blickarz C.E., Devarakonda T.J., et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng. 8:2002;739-751.
51. Rombouts W.J.C., Ploemacher R.E. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 17:2003;160-170.
52. DiGirolamo C.M., Stokes D., Colter D., Phinney D.G., Glass R., Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 107:1999;275-281.
53. Pittenger M.F., Mbalaviele G., Black M., Mosca J.D., Marshak D.R. Mesenchymal stem cells. Koller M.R., Palsson B.O., Master J.R.W. Human Cell Culture. 2001;189-207 Kluwer Academic Publishers, Great Britain.